Oncology Center Of Excellence Deputy Directors Kluetz, Theoret Join US FDA Exodus

 
• By Sue Sutter and Sarah Karlin-Smith
  
Exit sign
Voluntary departures are adding to the loss due to layoffs, early retirements and buyouts. (Shutterstock)

More from US FDA

More from Agency Leadership